Genmab — April 2017
-
http://finance.yahoo.com/news/syros-presents-data-aacr-further-120100400.html?soc_src=social-sh&soc_trk=tw Syros Pharmaceuticals , SY-1425 + daratumumab
-
https://www.clinicaltrials.gov/ct2/show/NCT02807558?term=SY-1425&rank=1 must be this study, even though dara isnt mentioned there
-
ved ikke om det har været nævnt - Jan solgte 70k aktier i går og David smed 35k aktier
-
...der kommer nok ikke en fredagsnyhed i denne uge...
-
forhåbentlig er de løse hænder blevet rystet af

-
kan det passe, at der ikke var en børsmeddelelse omkring det? Jeg fik nyheden fra finanstilsynets system - https://oasm.finanstilsynet.dk/dk/vismeddelelse.aspx?aid=a4c52cf8-3b66-4b4b-8879-cd151c94d3ae
-
Bestyrelsesmedlemmet Rolf Hoffmann har købt 575 aktier på 1290
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind